Southeast Asia News Desk

Kawasaki, Japan, August 6, 2025 – (JCN Newswire via SeaPRwire.com) – Fujitsu Limited today announced the release of its CHRO Roundtable Report 2025. The report is based on the third session of its CHRO Roundtable initiative which aims to advance human capital management at Japanese corporations by facilitating cross-industry discussions among Chief Human Resource Officers […]

Upgraded Mogami-class Frigate (4,800 ton type) (Image) TOKYO, August 5, 2025 – (JCN Newswire via SeaPRwire.com) – The Australian Government announced on August 5 that it has selected Mitsubishi Heavy Industries, Ltd. (MHI) to enter the next stage procurement process for Australia’s new General-Purpose frigates by selecting the Upgraded Mogami-class frigate as the preferred platform. […]

12 new Inventors bring total to 19 Phase 1’s official launch set for September 25 Woven City to serve as a test course for new forms of mobility that empower daily life TOKYO, Japan, August 4, 2025 – (JCN Newswire via SeaPRwire.com) – Toyota Motor Corporation (“Toyota”) and Woven by Toyota, Inc. (“WbyT”) today announced the […]

TOKYO, July 31, 2025 – (JCN Newswire via SeaPRwire.com) – TANAKA PRECIOUS METAL GROUP Co., Ltd. (Headquarters: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) has decided to enter into a business partnership with JEPLAN, INC. (Headquarters: Kawasaki City, Kanagawa; Representative Director, President, and Chief Executive Officer: Masaki Takao; hereinafter “JEPLAN”) to reduce CO₂ emissions and promote the […]

Santa Clara, CA, July 29, 2025, (ACN Newswire via SeaPRwire.com) – Meshy.ai, the world’s leading AI-powered 3D content generation platform, has launched the Meshy 5 Preview, offering early access to the next generation of AI 3D model generator. Built on the strong foundation of Meshy 4, this preview version introduces smarter generation tools, enhanced image […]

TOYOTA CITY, July 30, 2025 – (JCN Newswire via SeaPRwire.com) – Toyota Motor Corporation announces its sales, production, and export results for June 2025 as well as the cumulative total from January to June 2025, including those for subsidiaries Daihatsu Motor Co., Ltd. and Hino Motors, Ltd. For more details, please see the link below (detailed […]

TOKYO and CAMBRIDGE, Mass., July 31, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito,“Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A.Viehbacher, “Biogen”) announced today that the two-year real-world study in the U.S of lecanemab (generic name, product name: LEQEBMI®), an anti-AB protofibril* antibody, was […]

TOKYO, July 30, 2025 – (JCN Newswire via SeaPRwire.com) – Sharp Corporation has reached an agreement with Mitsubishi Chemical Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Manabu Tsukimoto), the National Institute of Information and Communications Technology (NICT) (Headquarters: Koganei City, Tokyo; President: Hideyuki Tokuda), and TECHLAB Co., Ltd. (Headquarters: Tama City, Tokyo; President: Hiroshi Hatakeyama) to collaboratively […]

Mitsubishi Heavy Industries aims to integrate DCIM (Data Center Infrastructure Management) into its One-stop solutions portfolio to offer digital services to data centers The combination delivers a comprehensive view of data center infrastructure, enabling enhanced visibility, elevated operational efficiency and optimized energy consumption TOKYO, July 29, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Heavy […]

Osaka, Japan, July 29, 2025 – (JCN Newswire via SeaPRwire.com) – Osaka Prefecture has finalized the detailed program for the OSAKA JAPAN SDGs Forum to be held on Friday, September 5, 2025. Under the Osaka SDGs Vision (formulated in 2020), Osaka Prefecture has set the goal of becoming a leading “SDGs advanced city” that contributes to […]

TOKYO, July 29, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that its in-house discovered tyrosine kinase inhibitor, “LENVIMA®” (generic name: lenvatinib mesylate), in combination with the anti-PD-1 antibody, pembrolizumab, and transarterial chemoembolization (TACE) has been approved by the National Medical Products Administration (NMPA) of […]